Clinical evidence requirements according to the IVDR 2017/746: practical tools and references for underpinning clinical evidence of IVD-MDs.

in vitro diagnostic 2017/746 IVDR analytical performance clinical evidence clinical performance performance evaluation

Journal

Clinical chemistry and laboratory medicine
ISSN: 1437-4331
Titre abrégé: Clin Chem Lab Med
Pays: Germany
ID NLM: 9806306

Informations de publication

Date de publication:
27 06 2023
Historique:
received: 09 12 2022
accepted: 27 02 2023
medline: 30 5 2023
pubmed: 16 3 2023
entrez: 15 3 2023
Statut: epublish

Résumé

In May 2022, the European Regulation 2017/746 (IVDR) came into force. It changes the approach of

Identifiants

pubmed: 36919280
pii: cclm-2022-1252
doi: 10.1515/cclm-2022-1252
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1150-1157

Informations de copyright

© 2023 the author(s), published by De Gruyter, Berlin/Boston.

Références

The European Parliament. Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU (Text with EEA relevance) [Internet]. OJ L; 2017. Available from: http://data.europa.eu/eli/reg/2017/746/oj/eng .
The European Parliament. Directive 98/79/EC of the european parliament and of the council of 27 October 1998 on in vitro diagnostic medical devices [Internet]. OJ L; 1998. Available from: http://data.europa.eu/eli/dir/1998/79/oj/eng .
The European Parliament. Regulation (EU) 2022/112 of the european parliament and of the council of 25 January 2022 amending regulation (EU) 2017/746 as regards transitional provisions for certain in vitro diagnostic medical devices and the deferred application of conditions for in-house devices (text with EEA relevance) [Internet]. OJ L; 2022. Available from: http://data.europa.eu/eli/reg/2022/112/oj/eng .
MedTech, Europe. Analysing the availability of IVDs in May 2022 [Internet - cited 2022 Aug 24]; 2022. Available from: https://www.medtecheurope.org/resource-library/medtech-europe-survey-report-analysing-the-availability-of-in-vitro-diagnostic-medical-devices-ivds-in-may-2022-when-the-new-eu-ivd-regulation-applies/ .
European Commission. New Approach Notified and Designated Organisations. [Internet - cited 2022 Aug 18]; 2022. Available from: https://ec.europa.eu/growth/tools-databases/nando/index.cfm?fuseaction=directive.notifiedbody&dir_id=35 .
Ries, F. Question parlementaire | Manque d’organismes notifiés à l’aube de la mise en application du règlement relatif aux dispositifs médicaux de diagnostic in vitro | P-001914/2022 | Parlement européen [Internet]; 2022. Available from: https://www.europarl.europa.eu/doceo/document/P-9-2022-001914_FR.html [Accessed 4 Jan 2023].
The Medical Device Coordination Group . Guidance - MDCG endorsed documents and other guidance [Internet - cited 2022 Aug 22]; 2022. Available from: https://health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en .
The European Parliament. EUR-Lex - 32022R0112 - EN - EUR-Lex [Internet - cited 2023 Feb 4]; 2022. Available from: https://eur-lex.europa.eu/eli/reg/2022/112/oj/eng .
Cobbaert, C, Capoluongo, ED, Vanstapel, FJLA, Bossuyt, PMM, Bhattoa, HP, Nissen, PH, et al.. Implementation of the new EU IVD regulation – urgent initiatives are needed to avert impending crisis. Clin Chem Lab Med 2022;60:33–43. https://doi.org/10.1515/cclm-2021-0975 .
doi: 10.1515/cclm-2021-0975
International Organization for Standardization. ISO 15189:2022 [Internet - cited 2023 Feb 4]. Available from: https://www.iso.org/fr/standard/76677.html .
The International Electrotechnical Commission. IEC 62304:2006+AMD1:2015 CSV | IEC Webstore | cyber security, smart city [Internet - cited 2023 Feb 4]. Available from: https://webstore.iec.ch/publication/22794 .
van Deutekom, HWM, Haitjema, S. Recommendations for IVDR compliant in-house software development in clinical practice: a how-to paper with three use cases. Clin Chem Lab Med 2022;60:982–8. https://doi.org/10.1515/cclm-2022-0278 .
doi: 10.1515/cclm-2022-0278
MedTech, Europe. IVD Regulation - Flowchart - Fact Sheets [Internet - cited 2022 Aug 22]; 2017. Available from: https://www.medtecheurope.org/resource-library/ivd-regulation-flowchart/ .
MedTech, Europe. Clinical Evidence Requirements for CE certification [Internet - cited 2022 Aug 22]; 2022. Available from: https://www.medtecheurope.org/resource-library/clinical-evidence-requirements-for-ce-certification-under-the-in-vitro-diagnostic-regulation-in-the-european-union/ .
Horvath, AR, Lord, SJ, StJohn, A, Sandberg, S, Cobbaert, CM, Lorenz, S, et al.. From biomarkers to medical tests: the changing landscape of test evaluation. Clin Chim Acta 2014;427:49–57. https://doi.org/10.1016/j.cca.2013.09.018 .
doi: 10.1016/j.cca.2013.09.018
Lesko, LJ, Zineh, I, Huang, SM. What is clinical utility and why should we care? Clin Pharmacol Ther 2010;88:729–33. https://doi.org/10.1038/clpt.2010.229 .
doi: 10.1038/clpt.2010.229
European commission. Public health : commission proposes a progressive roll-out of the new In Vitro Diagnostic Medical Devices Regulation [Internet - cited 2022 Aug 18]; 2021. Available from: https://ec.europa.eu/commission/presscorner/detail/en/ip_21_5209 .
International Organization for Standardization. ISO 20916:2019 [Internet - cited 2023 Feb 4]. Available from: https://www.iso.org/standard/69455.html .
Lord, SJ, St John, A, Bossuyt, PM, Sandberg, S, Monaghan, PJ, O’Kane, M, et al.. Setting clinical performance specifications to develop and evaluate biomarkers for clinical use. Ann Clin Biochem 2019;56:527–35. https://doi.org/10.1177/0004563219842265 .
doi: 10.1177/0004563219842265
International Organization for Standardization. ISO 17511:2020 [Internet - cited 2023 Feb 15]. Available from: https://www.iso.org/fr/standard/69984.html
Leeflang, MMG, Allerberger, F. How to: evaluate a diagnostic test. Clin Microbiol Infect 2019;25:54–9. https://doi.org/10.1016/j.cmi.2018.06.011 .
doi: 10.1016/j.cmi.2018.06.011
Nishikawa-Pacher, A. Research questions with PICO: a universal mnemonic. Publications 2022;10:21. https://doi.org/10.3390/publications10030021 .
doi: 10.3390/publications10030021
Page, MJ, Moher, D, Bossuyt, PM, Boutron, I, Hoffmann, TC, Mulrow, CD, et al.. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 2021;372:n160. https://doi.org/10.1136/bmj.n160 .
doi: 10.1136/bmj.n160
Page, MJ, McKenzie, JE, Bossuyt, PM, Boutron, I, Hoffmann, TC, Mulrow, CD, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. https://doi.org/10.1136/bmj.n71 .
doi: 10.1136/bmj.n71
Whiting, PF, Rutjes, AWS, Westwood, ME, Mallett, S, Deeks, JJ, Reitsma, JB, et al.. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:529–36. https://doi.org/10.7326/0003-4819-155-8-201110180-00009 .
doi: 10.7326/0003-4819-155-8-201110180-00009
Yang, B, Mallett, S, Takwoingi, Y, Davenport, CF, Hyde, CJ, Whiting, PF, et al.. QUADAS-C: a tool for assessing risk of bias in comparative diagnostic accuracy studies. Ann Intern Med 2021;174:1592–9. https://doi.org/10.7326/m21-2234 .
doi: 10.7326/m21-2234
Lee, J, Mulder, F, Leeflang, M, Wolff, R, Whiting, P, Bossuyt, PM. QUAPAS: an adaptation of the QUADAS-2 tool to assess prognostic accuracy studies. Ann Intern Med 2022;175:1010–8. https://doi.org/10.7326/m22-0276 .
doi: 10.7326/m22-0276
Sterne, JAC, Savović, J, Page, MJ, Elbers, RG, Blencowe, NS, Boutron, I, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898. https://doi.org/10.1136/bmj.l4898 .
doi: 10.1136/bmj.l4898
Sterne, JA, Hernán, MA, Reeves, BC, Savović, J, Berkman, ND, Viswanathan, M, et al.. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016;355:i4919. https://doi.org/10.1136/bmj.i4919 .
doi: 10.1136/bmj.i4919
European commissions. Commission implementing regulation (EU) 2022/1107 of 4 July 2022 laying down common specifications for certain class D in vitro diagnostic medical devices in accordance with regulation (EU) 2017/746 of the european parliament and of the council (text with EEA relevance) [Internet]. OJ L; 2022. Available from: http://data.europa.eu/eli/reg_impl/2022/1107/oj/eng .
World Health organization. Performance Evaluation . Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control). 2020 [Internet - cited 2023 Jan 17]. Available from: https://extranet.who.int/pqweb/vitro-diagnostics/performance-evaluation .
Global Harmonization Task Force Study Group 5 . International Medical Device Regulators Forum. Clinical Safety/Performance [Internet - cited 2023 Jan 19]; 2012. Available from: https://www.imdrf.org/documents/ghtf-final-documents/ghtf-study-group-5-clinical-safetyperformance .
Martin Bland, J, Altman, DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;327:307–10. https://doi.org/10.1016/s0140-6736(86)90837-8 .
doi: 10.1016/s0140-6736(86)90837-8
Cohen, J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37–46. https://doi.org/10.1177/001316446002000104 .
doi: 10.1177/001316446002000104
Stergiou, GS, Alpert, B, Mieke, S, Asmar, R, Atkins, N, Eckert, S, et al.. A universal standard for the validation of blood pressure measuring devices: association for the advancement of medical instrumentation/European society of hypertension/international organization for standardization (AAMI/ESH/ISO) collaboration statement. Hypertens Dallas Tex . 2018;71:368–74, https://doi.org/10.1161/hypertensionaha.117.10237 .
doi: 10.1161/hypertensionaha.117.10237
Sammut-Powell, C, Reynard, C, Allen, J, McDermott, J, Braybrook, J, Parisi, R, et al.. Examining the effect of evaluation sample size on the sensitivity and specificity of COVID-19 diagnostic tests in practice: a simulation study. Diagn Prognostic Res 2022;6:12. https://doi.org/10.1186/s41512-021-00116-4 .
doi: 10.1186/s41512-021-00116-4
Hajian-Tilaki, K. Sample size estimation in diagnostic test studies of biomedical informatics. J Biomed Inf 2014;48:193–204. https://doi.org/10.1016/j.jbi.2014.02.013 .
doi: 10.1016/j.jbi.2014.02.013
Fahie-Wilson, MN, Cobbaert, CM, Horvath, AR, Smith, TP. Interference by macroprolactin in assays for prolactin: will the in Vitro Diagnostics Regulation lead to a solution at last? Clin Chem Lab Med 2022;60:1350–5. https://doi.org/10.1515/cclm-2022-0460 .
doi: 10.1515/cclm-2022-0460

Auteurs

Karine Charrière (K)

Université de Franche-Comté, LINC, CIC 1431 INSERM, Centre Hospitalier Universitaire de Besançon, Besançon, France.

Lionel Pazart (L)

Université de Franche-Comté, LINC, CIC 1431 INSERM, Centre Hospitalier Universitaire de Besançon, Besançon, France.
Tech4Health Network, FCRIN, Besançon, France.

Articles similaires

Humans Female Music Adult Cognition
Humans Digital Technology Equipment and Supplies Pharmaceutical Preparations
Solvents Water Ethanol Humans Povidone
Biosimilar Pharmaceuticals United States Economic Competition Humans Patents as Topic

Classifications MeSH